High-risk ARGs (e.g., CBS, MYC, MMP3, CD36) promote tumor growth, immune evasion, and metastasis. TSP-1/CD36 axis inhibits angiogenesis and tumor progression. This evidence concerns the gene CD36 and neoplasm.